星空体育官方入口网站网址大全-登录入口官网

#MTX#

14篇内容 | 946人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2205190, encodeId=6c0022051908e, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a> <a href='/topic/show?id=33aa1088832d' target=_blank style='color:#2F92EE;'>#填充剂#</a>, objectTitle=确认过效果：低剂量口服甲氨蝶呤治疗皮肤填充剂迟发性炎症反应, objectType=article, longId=826260, objectId=bf04826260e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240517/1715927461816_5579292.jpg, objectUrl=/article/show_article.do?id=bf04826260e0, replyNumber=0, likeNumber=33, createdTime=2024-05-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bf04826260e0, moduleTitle=确认过效果：低剂量口服甲氨蝶呤治疗皮肤填充剂迟发性炎症反应, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bf04826260e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1717880, encodeId=151a1e17880ed, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=Colloids and Surfaces B：MTX+HCQ纳米胶束是传统给药方式疗效的3倍, objectType=article, longId=215556, objectId=a2d221555631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d221555631, replyNumber=0, likeNumber=72, createdTime=2021-09-21, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d221555631, moduleTitle=Colloids and Surfaces B：MTX+HCQ纳米胶束是传统给药方式疗效的3倍, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a2d221555631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717879, encodeId=97e41e178799e, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=Ann Rheum Dis：超早期使用依那西普和MTX vs MTX联合依那西普延迟治疗RA的随机对照试验, objectType=article, longId=188894, objectId=dc6f18889404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc6f18889404, replyNumber=0, likeNumber=63, createdTime=2020-05-25, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc6f18889404, moduleTitle=Ann Rheum Dis：超早期使用依那西普和MTX vs MTX联合依那西普延迟治疗RA的随机对照试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dc6f18889404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717878, encodeId=e2251e17878c8, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=Ann Rheum Dis：托珠单抗单药vs.阿达木单抗联合MTX治疗类风湿性关节炎骨侵蚀的疗效, objectType=article, longId=167196, objectId=dc4b16e19615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc4b16e19615, replyNumber=0, likeNumber=63, createdTime=2020-03-24, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc4b16e19615, moduleTitle=Ann Rheum Dis：托珠单抗单药vs.阿达木单抗联合MTX治疗类风湿性关节炎骨侵蚀的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dc4b16e19615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717877, encodeId=5f4a1e1787788, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=PLos One：RA患者MTX治疗期间肝活检中的非酒精性脂肪性肝炎样类型, objectType=article, longId=147397, objectId=35f714e397ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35f714e397ba, replyNumber=0, likeNumber=117, createdTime=2018-09-30, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35f714e397ba, moduleTitle=PLos One：RA患者MTX治疗期间肝活检中的非酒精性脂肪性肝炎样类型, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=35f714e397ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717876, encodeId=cae91e17876b9, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=LMTX (R)的第二次三期临床研究结果在《阿尔茨海默病期刊》上发表, objectType=article, longId=121575, objectId=04e61215e595, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04e61215e595, replyNumber=0, likeNumber=62, createdTime=2018-01-08, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04e61215e595, moduleTitle=LMTX (R)的第二次三期临床研究结果在《阿尔茨海默病期刊》上发表, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=04e61215e595)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717874, encodeId=079f1e17874c9, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=Pharmacotherapy：HDMTX治疗患者：尿液碱化pH阈值降低对结局有影响？, objectType=article, longId=107616, objectId=d5ac10e6167a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5ac10e6167a, replyNumber=0, likeNumber=93, createdTime=2018-01-04, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5ac10e6167a, moduleTitle=Pharmacotherapy：HDMTX治疗患者：尿液碱化pH阈值降低对结局有影响？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d5ac10e6167a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717871, encodeId=efca1e1787118, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=J Rheumatol：三联口服治疗与抗TNF联合MTX治疗MTX不应性类风湿的疗效比较, objectType=article, longId=96790, objectId=e66896e90a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66896e90a6, replyNumber=0, likeNumber=51, createdTime=2017-11-19, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66896e90a6, moduleTitle=J Rheumatol：三联口服治疗与抗TNF联合MTX治疗MTX不应性类风湿的疗效比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e66896e90a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717875, encodeId=88b31e1787552, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=Ann Rheum Dis： MTX单药与TNFi（阿达木单抗）联合MTX治疗早期类风湿关节炎的治疗靶向结局比较, objectType=article, longId=120545, objectId=777012054511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=777012054511, replyNumber=0, likeNumber=85, createdTime=2018-07-16, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=777012054511, moduleTitle=Ann Rheum Dis： MTX单药与TNFi（阿达木单抗）联合MTX治疗早期类风湿关节炎的治疗靶向结局比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=777012054511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717873, encodeId=7e2a1e17873f2, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=Ann Rheum Dis：治疗活动性类风湿关节炎GP2013和利妥昔单抗联合MTX具有生物等效性, objectType=article, longId=103145, objectId=ed31103145f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed31103145f9, replyNumber=0, likeNumber=116, createdTime=2017-07-17, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed31103145f9, moduleTitle=Ann Rheum Dis：治疗活动性类风湿关节炎GP2013和利妥昔单抗联合MTX具有生物等效性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ed31103145f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717872, encodeId=ff151e17872ee, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=Arthritis Rheumatol：多生物标志物疾病活动评分和MTX治疗失败后早期类风湿关节炎的二线治疗选择, objectType=article, longId=97445, objectId=ca789e44586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca789e44586, replyNumber=0, likeNumber=89, createdTime=2018-01-21, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca789e44586, moduleTitle=Arthritis Rheumatol：多生物标志物疾病活动评分和MTX治疗失败后早期类风湿关节炎的二线治疗选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ca789e44586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717869, encodeId=831e1e1786923, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=阿尔茨海默病新药LMTX三期临床试验失败，30年努力是否白费？, objectType=article, longId=74035, objectId=296ce403503, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=296ce403503, replyNumber=0, likeNumber=82, createdTime=2016-09-01, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=296ce403503, moduleTitle=阿尔茨海默病新药LMTX三期临床试验失败，30年努力是否白费？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=296ce403503)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717870, encodeId=122d1e17870e5, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=【盘点】新药LMTX三期临床试验失败，再看阿尔兹海默症前沿进展, objectType=article, longId=74291, objectId=1a3ce429101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a3ce429101, replyNumber=0, likeNumber=67, createdTime=2016-08-29, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a3ce429101, moduleTitle=【盘点】新药LMTX三期临床试验失败，再看阿尔兹海默症前沿进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1a3ce429101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717868, encodeId=6e861e1786881, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=针对Tau蛋白的老年性痴呆“特效药”LMTX三期临床试验失败，未来前景难测, objectType=article, longId=74010, objectId=4ecce4010b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ecce4010b6, replyNumber=0, likeNumber=92, createdTime=2016-08-26, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ecce4010b6, moduleTitle=针对Tau蛋白的老年性痴呆“特效药”LMTX三期临床试验失败，未来前景难测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4ecce4010b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717867, encodeId=24911e178678a, content=<a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a>, objectTitle=Gynecol Obstet Invest：子宫动脉栓塞术（UAE）和氨甲喋呤（MTX）保守治疗剖宫产术后瘢痕妊娠的疗效比较, objectType=article, longId=57381, objectId=323f5e38116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=323f5e38116, replyNumber=0, likeNumber=86, createdTime=2016-06-25, rootId=0, userName=july_986, userId=94f232475516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=323f5e38116, moduleTitle=Gynecol Obstet Invest：子宫动脉栓塞术（UAE）和氨甲喋呤（MTX）保守治疗剖宫产术后瘢痕妊娠的疗效比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=323f5e38116)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MTX

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #MTX# #填充剂#

确认过效果：低剂量口服甲氨蝶呤治疗皮肤填充剂迟发性炎症反应

2024-05-17发表于上海

july_986 (审核中...)

前往app查看评论内容

#MTX#

Colloids and Surfaces B：MTX+HCQ纳米胶束是传统给药方式疗效的3倍

2021-09-21

july_986 (审核中...)

前往app查看评论内容

#MTX#

Ann Rheum Dis：超早期使用依那西普和MTX vs MTX联合依那西普延迟治疗RA的随机对照试验

2020-05-25

july_986 (审核中...)

前往app查看评论内容

#MTX#

Ann Rheum Dis：托珠单抗单药vs.阿达木单抗联合MTX治疗类风湿性关节炎骨侵蚀的疗效

2020-03-24

july_986 (审核中...)

前往app查看评论内容

#MTX#

PLos One：RA患者MTX治疗期间肝活检中的非酒精性脂肪性肝炎样类型

2018-09-30

july_986 (审核中...)

前往app查看评论内容

#MTX#

LMTX (R)的第二次三期临床研究结果在《阿尔茨海默病期刊》上发表

2018-01-08

july_986 (审核中...)

前往app查看评论内容

#MTX#

Pharmacotherapy：HDMTX治疗患者：尿液碱化pH阈值降低对结局有影响？

2018-01-04

july_986 (审核中...)

前往app查看评论内容

#MTX#

J Rheumatol：三联口服治疗与抗TNF联合MTX治疗MTX不应性类风湿的疗效比较

2017-11-19

july_986 (审核中...)

前往app查看评论内容

#MTX#

Ann Rheum Dis： MTX单药与TNFi（阿达木单抗）联合MTX治疗早期类风湿关节炎的治疗靶向结局比较

2018-07-16

july_986 (审核中...)

前往app查看评论内容

#MTX#

Ann Rheum Dis：治疗活动性类风湿关节炎GP2013和利妥昔单抗联合MTX具有生物等效性

2017-07-17

july_986 (审核中...)

前往app查看评论内容

#MTX#

Arthritis Rheumatol：多生物标志物疾病活动评分和MTX治疗失败后早期类风湿关节炎的二线治疗选择

2018-01-21

july_986 (审核中...)

前往app查看评论内容

#MTX#

阿尔茨海默病新药LMTX三期临床试验失败，30年努力是否白费？

2016-09-01

july_986 (审核中...)

前往app查看评论内容

#MTX#

【盘点】新药LMTX三期临床试验失败，再看阿尔兹海默症前沿进展

2016-08-29

july_986 (审核中...)

前往app查看评论内容

#MTX#

针对Tau蛋白的老年性痴呆“特效药”LMTX三期临床试验失败，未来前景难测

2016-08-26

july_986 (审核中...)

前往app查看评论内容

#MTX#

Gynecol Obstet Invest：子宫动脉栓塞术（UAE）和氨甲喋呤（MTX）保守治疗剖宫产术后瘢痕妊娠的疗效比较

2016-06-25

科室
- - 订阅+
  - 更多科室
工具
服务